Clinical Trial: SLND Versus Non-Dissection Following ESD for T1a Stage Esophageal Squamous Cell Carcinoma

U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT06979986) titled 'SLND Versus Non-Dissection Following ESD for T1a Stage Esophageal Squamous Cell Carcinoma' on May 01.

Brief Summary: This is a study from Fujian Cancer Hospital Thoracic of Surgery Project, numbered as FJCHTOSP-1. Systematically mediastinal Lymph Node Dissection (SLD) Versus Non-Dissection Following Endoscopic Submucosal Dissection (ESD) for T1a Stage Esophageal Squamous Cell Carcinoma: a single-center, prospective clinical trial.

Study Start Date: June 01

Study Type: INTERVENTIONAL

Condition: Esophageal Cancer

Intervention: PROCEDURE: Endoscopic Submucosal Dissection with Systematically mediastinal Lymph Node Dissection

Parti...